Displaying all 2 publications

Abstract:
Sort:
  1. Afzal M, Abusalah MAHA, Shehzadi N, Absar M, Ahmed N, Khan S, et al.
    PLoS One, 2025;20(1):e0310103.
    PMID: 39847593 DOI: 10.1371/journal.pone.0310103
    Mushrooms are considered one of the safe and effective medications because they have great economic importance due to countless biological properties. Cordyceps militaris contains bioactive compounds with antioxidant, antimicrobial and anti-cancerous properties. This study was projected to analyze the potentials of biometabolites and to extract antimicrobial peptides and protein from the C. militaris. An in-vitro analysis of biometabolites and antimicrobial peptides was performed to investigate their pharmacological potentials followed by quantification and characterization of extracted protein. Computational analysis on non-small cell lung cancer genes (NSCLC) was performed on quantified compounds to interpret the biometabolites from C. militaris that could be potential drug candidate molecules with high specificity and potency. A total of 34 compounds representing 100% of total detected constituents identified were identified using GCMS analysis and 20 compounds using LC-MS which showed strong biological activities. FT-IR spectroscopy manifest powerful instant peaks to have different bioactive components including carboxylic acid, phenols, amines and alkanes present in methanolic extract of C. militaris. In C. militaris, higher protein concentration was observed in 70% concentration of protein extract (500 μg/ml ± 0.025). The best antioxidant activity (% Radical scavenging activity) of methanolic extracts was 80a ± 0.03, antidiabetic activity was 37 ± 0.057 and anti-inflammatory activity was 40 ± 0.021 at 12 mg/ml. Antibacterial activity for different concentrations of Cordyceps protein and methanolic extracts was significantly (p < 0.05). Indolizine, 2-(4-methylphenyl) has most binding affinity (micromolar) and optimized properties to be selected as the lead inhibitor. It interacts favorably with the active site of RET gene of NSCLC and is neuroprotective and hepatoprotective.
  2. Tanvir S, Syed SA, Mohyuddin Z, Khan AM, Sheikh J, Mehmood N, et al.
    Biomed Tech (Berl), 2026 Nov 03.
    PMID: 42969167 DOI: 10.1515/bmt-2026-0534
    OBJECTIVES: To develop and validate a YOLOv11-based deep learning framework that automatically segments vitiligo lesions in standardized clinical photographs captured under controlled conditions, enabling reproducible lesion quantification across longitudinal visits.

    METHODS: Standardized photographs from 18 patients were acquired at baseline, 3 months, and 6 months under controlled imaging conditions, including fixed lighting, camera settings, and color calibration. Images underwent preprocessing involving resizing, color and illumination normalization, noise reduction, and geometric standardization. Expert dermatologists generated binary lesion masks that were used as ground truth for training a one-stage YOLOv11 segmentation model. Model performance was evaluated using patient-wise data splits and 5-fold cross-validation.

    RESULTS: The proposed model achieved 95 % accuracy, 92 % precision, 89 % recall, 90 % F1-score, with mAP@0.5 values of 0.878 (bounding box) and 0.892 (mask) from precision-recall analysis. Qualitative review indicated consistent segmentation quality across follow-up visits and moderate illumination variations, though formally stratified quantitative analysis by visit was not performed in this study. Visual assessment demonstrated close agreement between predicted and expert-annotated lesion boundaries, with minor under-segmentation observed mainly in low-contrast peripheral regions.

    CONCLUSIONS: Standardized clinical photography combined with a YOLOv11-based segmentation framework enables reliable vitiligo lesion delineation and has potential for integration into quantitative disease monitoring and clinical decision-support systems.

Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links